These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 718735)

  • 21. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
    Roztocil K; Oliva J; Linhart J; Prerovský I; Modr Z
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):135-8. PubMed ID: 844932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Action of pyridinol carbamate on hetero-immune Masugi nephritis in the rat (author's transl)].
    Lagrue G; Hirbec G; Moisy M; Sternberg M; Blanc C
    Pathol Biol (Paris); 1976 Sep; 24(7):477-81. PubMed ID: 790274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of clofibrate on cholesterol and lipid metabolism in ethanol - treated mice.
    Rawat AK
    Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):501-10. PubMed ID: 1135514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clofibrate and phosphate metabolism].
    Michailov ML
    Cor Vasa; 1984; 26(4):309-16. PubMed ID: 6488804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preliminary study of a work concerning the activity of pyridinol carbamate on diabetic angiopathy (study of the microcirculation)].
    Le Devehat C; Lemoine A
    Journ Annu Diabetol Hotel Dieu; 1977; ():389-93. PubMed ID: 894879
    [No Abstract]   [Full Text] [Related]  

  • 26. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract]   [Full Text] [Related]  

  • 27. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction.
    Horváth M; Mezey Z; Jósfay A; Nánay I; Varsányi M; Geró S
    J Investig Allergol Clin Immunol; 1991 Dec; 1(6):404-10. PubMed ID: 1669600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopharmaceutical studies on pyridinolcarbamate. V. Effect of repeated administration of pyridinolcarbamate on the renal excretion of sulbenicillin in rabbits.
    Suenaga A; Nakagawa H; Huang MT; Imamura Y; Otagiri M; Ichibagase H
    Acta Pharm Suec; 1985; 22(1):45-52. PubMed ID: 4024967
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental atherosclerosis in hypercholesterolemic mini-pigs. Regression of cholesterol ester accumulation in aorta and coronary arteries after treatment with clofibrate, beta-pyridylcarbinol or a normo-lipidemic diet.
    Jacobsson L; Lundholm L
    Atherosclerosis; 1982 Nov; 45(2):129-48. PubMed ID: 6760875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of phenformin, pyridinolcarbamate combined with a decalcifying agent, and an onion--garlic mixture on growth and necrosis of aortic atherosclerosis in ballooned swine.
    Lee WM; Lee KT
    Exp Mol Pathol; 1980 Dec; 33(3):345-8. PubMed ID: 6450054
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of pyridinol carbamate. I. Gas chromatographic determination of pyridinol carbamate].
    Laukó A; Görög S
    Acta Pharm Hung; 1986 May; 56(3):129-32. PubMed ID: 3739725
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P
    Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement of ADP-induced platelet aggregation by cholesterol and its prevention by pyridinolcarbamate.
    Sano T; Yamazaki H; Shimamoto T
    Thromb Diath Haemorrh; 1973 Jun; 29(3):684-93. PubMed ID: 4761834
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of clofibrate on aortic glycosamine-glycans and proteins and on serum lipid levels in experimental atherosclerosis.
    Bihari-Varga M; Fehér J; Varsányi M; Gerö S
    Acta Med Acad Sci Hung; 1973; 29(3):217-29. PubMed ID: 4270563
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of autologous sera and various drugs on the migration inhibition induced by vascular extracts in patients with coronary and peripheral arteriosclerosis.
    Gerö S; Horváth M; Szondy E
    Ric Clin Lab; 1982; 12(1):127-35. PubMed ID: 7089422
    [No Abstract]   [Full Text] [Related]  

  • 37. [Protective effect of carbamate pyridinol on experimental atheroma in the rat].
    Bouissou H; Julian M; Pieraggi MT
    Pathol Biol (Paris); 1974 Oct; 22(8):713-20. PubMed ID: 4614172
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and bioavailability of pyridinol carbamate in humans.
    Sassard J; Bernard N; Legheand J; Cuisinaud G; Traeger J
    J Pharm Sci; 1979 Sep; 68(9):1190-1. PubMed ID: 501551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of ileal bypass versus administration of clofibrate on experimental hypercholesterolemia and atherosclerosis in monkeys.
    Younger RK; Curtis JJ; Butts WH; Scott HW
    South Med J; 1976 Sep; 69(9):1141-2, 1145. PubMed ID: 823644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of CH-1243, a pyrido (1,2-a) pyrimidine derivative on the elevated activity of lysosomal enzymes of rabbit aorta and liver in experimental atherosclerosis.
    Ecsedi GG; Virág S; Hidvégi EJ
    Atherosclerosis; 1981 May; 39(2):183-90. PubMed ID: 7247998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.